SOURCE Sama Fertility

First full-cycle remote IVF protocol aims to make fertility care more affordable and accessible

NEW YORK, July 2, 2025 /PRNewswire/ -- Sama Fertility, a technology-enabled fertility care provider, today announced the launch of SimpleIVF, the first fully at-home, clinically validated IVF and egg freezing protocol in the United States. To date, Sama has raised $3.8 million from SNR Ventures, with additional investment from Ford Street Ventures, Artesian, Rootspring Ventures, and the Sequoia Scout Program to accelerate development of its intelligent care delivery platform.

Unlike traditional fertility care, which requires multiple in-person visits for consultations, testing, and monitoring, SimpleIVF allows patients to manage their entire treatment journey from home at one-third the cost of the national average. Nearly 10 million women in the U.S. face infertility, yet most can't access care due to the $30,000 average price tag for IVF. Sama removes both geographic and financial barriers with proprietary at-home tools and a fully integrated, tech-enabled platform. By standardizing care and using real-time data to guide each step, Sama lowers costs, reduces variability, and delivers a scalable model built for today's patients.

The current fertility system is also constrained by a severe provider shortage. Only about 1,000 fertility doctors serve the entire U.S., resulting in bottlenecks, and in some regions, wait times as long as 18 months.

"Most people either don't live near a fertility clinic or face a system filled with upsells and delays," said Sarthak S. Sawarkar, CEO of Sama Fertility. "This is essential care, yet it's financially out of reach for most especially since it's rarely covered by insurance. A single cycle of traditional IVF can go as high as $40,000 per cycle in some regions, but with SimpleIVF we've brought that down to $6,000 while maintaining clinical outcomes. It brings IVF within reach for far more people without lowering the standard of care."

At Home Fertility Care: How It Works

Sama's platform introduces a new category of "self-driving" fertility care - systems that automatically advance treatment based on real-time patient data instead of relying on clinic staff to manually coordinate every step. With portable ultrasound devices and instant lab access, Sama tracks every signal and activates the next step when the patient is ready. This approach reduces manual administrative work by over 90%, enabling a clinical team to safely support more patients without sacrificing personalization or safety.

Clinical Validation and Outcomes

Sama's model has demonstrated strong clinical results and earned SART certification, underscoring its effectiveness. Outcomes include over 300 egg retrievals and more than 30 babies born, with success rates consistently above the national average.

At the 2025 ASRM Scientific Congress & Expo, Sama will present data from three separate studies it conducted, all of which have been accepted for presentation and show groundbreaking results.. Sama will present new data showing how a series of at-home ultrasound scans can predict key moments in the IVF cycle - pointing to the potential for fewer in-clinic visits during treatment.

The second and third abstracts focus on how AI and automation can streamline fertility care. One describes a system that helps guide patients through IVF in a more efficient and personalized way. The other introduces an AI tool that could develop simpler, lower-cost treatment protocols making IVF more affordable and accessible.

Medical Partners

Sama works with its own network of contracted fertility doctors to deliver care through its platform. Additionally, CNY Fertility - a leading full-service clinic - is the first to launch with Sama, helping to bring this new model to market.

Dr. Melvin H. Thornton II, a globally recognized expert in reproductive medicine and a double board-certified OB/GYN and reproductive endocrinologist, played an advisory role in Sama's early validation. With more than 25 years of experience and a background that includes Columbia University and The Cleveland Clinic, Dr. Thornton has seen firsthand how Sama's model compares to in-clinic protocols.

"Through working with early users of Sama's at-home system, I've seen firsthand that the outcomes consistently match - or even exceed - those from traditional clinic settings," said Dr. Thornton, currently practicing at Global Fertility & Genetics in New York. "The science is solid, but what also sets it apart is how it addresses the real barriers patients face - whether it's the lack of local specialists in places like middle America, the stress and time commitment of frequent clinic visits and lab work, or the need for greater privacy. This model gives patients flexibility, more affordable care, and access on their terms. I've worked with families across the Tri-State for decades, and I believe this approach has the power to revolutionize fertility care for those who've been left out."

Sama's national waitlist is now open, with care available to patients across the U.S. starting today.

About Sama Fertility

Sama Fertility is a technology-enabled fertility care provider pioneering accessible, affordable, and patient-centered reproductive health solutions. By combining proprietary at-home tools with an intelligent digital platform and a network of contracted fertility doctors, Sama delivers fully remote IVF and egg freezing protocols that reduce costs by up to one-third while maintaining high clinical standards. Reported to SART and validated through clinical outcomes, Sama's innovative "self-driving" fertility care system leverages real-time patient data and automation to streamline treatment, increase scalability, and improve patient experience. Sama's mission is to democratize fertility care, making it accessible to millions of women and couples nationwide regardless of location or financial barriers. For more information, visit https://sama.life/.

Media Contact:
Nadia Jamshidi
[email protected]

©PR Newswire. All Rights Reserved.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]